O R I G I N a L I N V E S T I G a T I O N Open Access the Role of Profilin-1 in Endothelial Cell Injury Induced by Advanced Glycation End Products (ages)
暂无分享,去创建一个
[1] S. Shoelson,et al. Profilin-1 Haploinsufficiency Protects Against Obesity-Associated Glucose Intolerance and Preserves Adipose Tissue Immune Homeostasis , 2013, Diabetes.
[2] M. Yokoro,et al. Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction , 2013, Diabetes & vascular disease research.
[3] A. Ceriello. The emerging challenge in diabetes: the "metabolic memory". , 2012, Vascular pharmacology.
[4] Hong Li,et al. Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells , 2012, Cardiovascular Diabetology.
[5] Hongxia Liu,et al. RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response , 2012, Cardiovascular Diabetology.
[6] M. Odenthal,et al. Profilin-1 Is Expressed in Human Atherosclerotic Plaques and Induces Atherogenic Effects on Vascular Smooth Muscle Cells , 2010, PloS one.
[7] P. Home,et al. The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease , 2010, Current cardiology reviews.
[8] Merlin C. Thomas,et al. Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase , 2010, Journal of hypertension.
[9] A. Hirose,et al. Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway , 2010, FEBS letters.
[10] M. Ihnat,et al. Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? , 2009, The Journal of clinical endocrinology and metabolism.
[11] Li-jun Wang,et al. Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas. , 2008, European journal of pharmacology.
[12] S. Yamagishi,et al. Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications. , 2008, Current pharmaceutical design.
[13] Z. Guo,et al. Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. , 2008, Antioxidants & redox signaling.
[14] A. Kazlauskas,et al. Oxysterol and Diabetes Activate STAT3 and Control Endothelial Expression of Profilin-1 via OSBP1* , 2008, Journal of Biological Chemistry.
[15] A. Malik,et al. Regulation of Endothelial Junctional Permeability , 2008, Annals of the New York Academy of Sciences.
[16] H. Makino,et al. Regulation of Src homology 2-containing protein tyrosine phosphatase by advanced glycation end products: the role on atherosclerosis in diabetes. , 2007, Metabolism: clinical and experimental.
[17] A. Kazlauskas,et al. Attenuated Expression of Profilin-1 Confers Protection From Atherosclerosis in the LDL Receptor–Null Mouse , 2007, Circulation research.
[18] Bernd Stratmann,et al. Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. , 2007, The American journal of clinical nutrition.
[19] P. Roy,et al. Silencing profilin-1 inhibits endothelial cell proliferation, migration and cord morphogenesis , 2006, Journal of Cell Science.
[20] Mingde Zhao,et al. Advanced glycation end products induce actin rearrangement and subsequent hyperpermeability in endothelial cells , 2006 .
[21] M. Morales,et al. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes. , 2004, Life sciences.
[22] R. de Caterina,et al. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. , 2004, Cardiovascular research.
[23] J. Mamputu,et al. Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products: inhibitory effect of gliclazide , 2004, Diabetes, obesity & metabolism.
[24] H. Parving,et al. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes. , 2004, Diabetes care.
[25] N. Savion,et al. Flow Conditions Modulate Homocysteine Induced Changes in the Expression of Endothelial Cell Genes Associated with Cell-Cell Interaction and Cytoskeletal Rearrangement , 2002, Thrombosis and Haemostasis.
[26] Timothy S Kern,et al. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. , 2002, Diabetes.
[27] K. Otero,et al. Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells. , 2001, The Biochemical journal.
[28] G. King,et al. The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO‐MCBN, the American Diabetes Association and the German Diabetes Society , 2001, Diabetes/metabolism research and reviews.
[29] J. Nejima,et al. Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients , 2001, Heart.
[30] Y. Kaneda,et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.
[31] R. H. Sohn,et al. Regulation of endothelial cell adhesion by profilin , 1997, Current Biology.
[32] G. Santulli,et al. Cardiovascular Diabetology , 2023 .
[33] S. Yamagishi,et al. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression. , 2013, The American journal of pathology.
[34] W. Zhan. The Morphological Changes of Vascular Endothelial Cadherin in Human Umbilical Vein Endothelial Cells Induced by Advanced Glycation End Products , 2008 .
[35] A. Verin,et al. Molecular Mechanisms of Thrombin-Induced Endothelial Cell Permeability , 2004, Biochemistry (Moscow).